{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:04:21Z","timestamp":1793307861032,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec id=\"ab-crv240003-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Desmoid tumor (DT) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Previously, surgery was the standard primary treatment modality; however, within the past decade, a paradigm shift toward less-invasive management has been introduced and an effort to harmonize the strategy among clinicians has been made. To update the 2020 global evidence-based consensus guideline on the management of patients with DT, the Desmoid Tumor Working Group convened a 1-day consensus meeting in Milan, Italy, on June 30, 2023, under the auspices of the European Reference Network on Rare Adult Solid Cancers and Sarcoma Patient Advocacy Global Network, the Desmoid Foundation Italy, and the Desmoid Tumor Research Foundation. The meeting brought together over 90 adult and pediatric sarcoma experts from different disciplines as well as patients and patient advocates from around the world.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-crv240003-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>The 2023 update of the global evidence-based consensus guideline focused on the positioning of local therapies alongside surgery and radiotherapy in the treatment algorithm as well as the positioning of the newest class of medical agents, such as \u03b3-secretase inhibitors. Literature searches of MEDLINE and Embase databases were performed for English-language randomized clinical trials (RCTs) of systemic therapies to obtain data to support the consensus recommendations. Of the 18 full-text articles retrieved, only 4 articles met the inclusion criteria. The 2023 consensus guideline is informed by a number of new aspects, including data for local ablative therapies such as cryotherapy; other indications for surgery; and the \u03b3-secretase inhibitor nirogacestat, the first representative of the newest class of medical agents and first approved drug for DT. Management of DT is complex and should be carried out exclusively in designated DT referral centers equipped with a multidisciplinary tumor board. Selection of the appropriate strategy should consider DT-related symptoms, associated risks, tumor location, disease morbidities, available treatment options, and preferences of individual patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-crv240003-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The therapeutic armamentarium of DT therapy is continually expanding. It is imperative to carefully select the management strategy for each patient with DT to optimize tumor control and enhance quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoncol.2024.1805","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:02:42Z","timestamp":1718881362000},"page":"1121","source":"Crossref","is-referenced-by-count":119,"title":["Current Management of Desmoid Tumors"],"prefix":"10.1001","volume":"10","author":[{"given":"Bernd","family":"Kasper","sequence":"first","affiliation":[{"name":"Sarcoma Unit, Mannheim Cancer Center (MCC), Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Baldini","sequence":"additional","affiliation":[{"name":"Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bonvalot","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institut Curie, Comprehensive Cancer Center, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Callegaro","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Cardona","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine and Winship Cancer Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Colombo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Corradini","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Centre L\u00e9on B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Crago","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo P.","family":"Dei Tos","sequence":"additional","affiliation":[{"name":"Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma","family":"Dileo","sequence":"additional","affiliation":[{"name":"Department of Oncology, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldad","family":"Elnekave","sequence":"additional","affiliation":[{"name":"Unit of Interventional Radiology, Shaare Tzedek Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Erinjeri","sequence":"additional","affiliation":[{"name":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Navid","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children\u2019s Hospital Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Farma","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Deparment of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gladdy","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University of Toronto, Ontario, Canada"},{"name":"Department of Surgery, Mount Sinai Hospital, Sinai Health Systems, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Gounder","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick L.","family":"Haas","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, the Netherlands Cancer Institute, Amsterdam, the Netherlands"},{"name":"Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Husson","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kurtz","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Oncology & Hematology, Institut de Canc\u00e9rologie Strasbourg Europe (ICANS), Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Lazar","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[{"name":"SIREDO (Care, Innovation & Research in Childhood, Adolescent & Young-Adult Oncology) Oncology Center, Institut Curie, Paris Sciences et Lettres University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centre Oscar Lambret, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Ratan","sequence":"additional","affiliation":[{"name":"Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrajit P.","family":"Raut","sequence":"additional","affiliation":[{"name":"Department of Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Roland","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Rose W.","family":"Schut","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sparber-Sauer","sequence":"additional","affiliation":[{"name":"Stuttgart Cancer Center, Zentrum f\u00fcr Kinder- und Jugend Frauenmedizin, P\u00e4diatrie 5, Klinikum Stuttgart, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk C.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Sarcoma and Melanoma Unit, Department of Academic Surgery, The Royal Marsden NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette T. A.","family":"Van der Graaf","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vitellaro","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Pediatrics, Maine Medical Center, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Desmoid Tumor Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Alman","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Attia","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Bajpai","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Giulio","family":"Baldi","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Barbieri","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Baumgarten","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Benson","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Boye","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Brennan","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Domenico","family":"Campanacci","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Giovanni","family":"Casali","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Casanova","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Wie-Wu","family":"Chen","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"D'Ambrosio","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaves Maria Carolina","family":"De Menezes","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Dufresne","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Roland","family":"D\u00fcrr","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Frezza","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gyorki","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Hackett","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Haller","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Helaine","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hohenberger","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Iwata","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L","family":"Jones","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kelany","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Kirsch","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leithner","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Macneill","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Messiou","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Maki","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Morosi","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Napolitano","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nishida","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Palassini","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyaskumar","family":"Patel","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Personeni","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Pollock","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Rausa","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Roets","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Rossi","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Salvatore","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sangalli","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sbaraglia","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Michael","family":"Smith","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stacchiotti","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tap","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Tinoco","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Tzanis","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel AJ","family":"Van de Sande","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Van der Zande","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winan","family":"Van Houdt","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wagner","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Wardelmann","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Whiting","sequence":"additional","affiliation":[{"name":"for the Desmoid Tumor Working Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"crv240003r1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejca.2016.02.008","article-title":"Management of desmoid tumours: a nationwide survey of labelled reference centre networks in France.","volume":"58","author":"Penel","year":"2016","journal-title":"Eur J Cancer"},{"issue":"5","key":"crv240003r2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1634\/theoncologist.2010-0281","article-title":"Desmoid tumors: clinical features and treatment options for advanced disease.","volume":"16","author":"Kasper","year":"2011","journal-title":"Oncologist"},{"issue":"2","key":"crv240003r3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2014.11.005","article-title":"Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients\u2019 and professionals\u2019 expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer\/Soft Tissue and Bone Sarcoma Group initiative.","volume":"51","author":"Kasper","year":"2015","journal-title":"Eur J Cancer"},{"issue":"10","key":"crv240003r4","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/annonc\/mdx323","article-title":"An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma Patients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG).","volume":"28","author":"Kasper","year":"2017","journal-title":"Ann Oncol"},{"key":"crv240003r5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients.","volume":"127","author":"Desmoid Tumor Working Group","year":"2020","journal-title":"Eur J Cancer"},{"issue":"4","key":"crv240003r6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"25","key":"crv240003r7","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors.","volume":"379","author":"Gounder","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"crv240003r8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S1470-2045(19)30276-1","article-title":"Pazopanib or Methotrexate-Vinblastine Combination Chemotherapy in Adult Patients With Progressive Desmoid Tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.","volume":"20","author":"Toulmonde","year":"2019","journal-title":"Lancet Oncol"},{"issue":"18","key":"crv240003r9","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1158\/1078-0432.CCR-21-4504","article-title":"Systemic chemotherapies retain antitumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: a multi-institutional retrospective study.","volume":"28","author":"Nathenson","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"10","key":"crv240003r10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a ?-secretase inhibitor for desmoid tumors.","volume":"388","author":"Gounder","year":"2023","journal-title":"N Engl J Med"},{"issue":"13","key":"crv240003r11","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1245\/s10434-023-14341-2","article-title":"Initial active surveillance strategy for patients with peripheral sporadic primary desmoid-type fibromatosis: a multicentric phase II pbservational trial.","volume":"30","author":"Bonvalot","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"crv240003r12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/SLA.0000000000005415","article-title":"A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis: the GRAFITI trial.","volume":"277","author":"Schut","year":"2023","journal-title":"Ann Surg"},{"issue":"18","key":"crv240003r13","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1158\/1078-0432.CCR-21-4205","article-title":"A prospective observational study of active surveillance in primary desmoid fibromatosis.","volume":"28","author":"Colombo","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"2","key":"crv240003r14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00256-009-0801-z","article-title":"Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors.","volume":"39","author":"Kujak","year":"2010","journal-title":"Skeletal Radiol"},{"issue":"1","key":"crv240003r15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2214\/AJR.15.14391","article-title":"Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience.","volume":"207","author":"Schmitz","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"crv240003r16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2020.10.035","article-title":"CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment.","volume":"143","author":"Kurtz","year":"2021","journal-title":"Eur J Cancer"},{"issue":"7","key":"crv240003r17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3109\/02656736.2011.597047","article-title":"Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: preliminary results.","volume":"27","author":"Wang","year":"2011","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"crv240003r18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/02656736.2019.1608376","article-title":"Mid-term results of MR-guided high-intensity focused ultrasound treatment for relapsing superficial desmoids.","volume":"36","author":"Najafi","year":"2019","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"crv240003r19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/02656736.2021.1894359","article-title":"The safety and ablation efficacy of ultrasound-guided high-intensity focused ultrasound ablation for desmoid tumors.","volume":"38","author":"Zhang","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"4","key":"crv240003r20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ultrasmedbio.2021.12.002","article-title":"High-intensity focused ultrasound ablation for post-operative recurrent desmoid tumors: preliminary results.","volume":"48","author":"Mo","year":"2022","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"crv240003r21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/life13030645","article-title":"Role of the interventional radiologist in the treatment of desmoid tumors.","volume":"13","author":"Goldberg","year":"2023","journal-title":"Life (Basel)"},{"issue":"10","key":"crv240003r22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jvir.2018.04.009","article-title":"Doxorubicin-eluting intra-arterial therapy for pediatric extra-abdominal desmoid fibromatoses: a promising approach for a perplexing disease.","volume":"29","author":"Elnekave","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"20","key":"crv240003r23","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.3390\/cancers14205045","article-title":"Selective intra-arterial doxorubicin eluting microsphere embolization for desmoid fibromatosis: a combined prospective and retrospective study.","volume":"14","author":"Elnekave","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"crv240003r24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-022-03149-4","article-title":"Transarterial chemoembolization with doxorubicin eluting beads for extra-abdominal desmoid tumors: initial experience.","volume":"45","author":"Kim","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"crv240003r25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/1078-0432.CCR-14-0607","article-title":"A phase I, dose-finding study in patients with advanced solid malignancies of the oral ?-secretase inhibitor PF-03084014.","volume":"21","author":"Messersmith","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"3","key":"crv240003r26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/cncr.v126.3","article-title":"Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis.","volume":"126","author":"Gounder","year":"2020","journal-title":"Cancer"},{"key":"crv240003r27","doi-asserted-by":"publisher","first-page":"S1227","DOI":"10.1016\/j.annonc.2022.07.1591","article-title":"Initial results of phase II\/III trial of AL102 for treatment of desmoid tumors (DT).","volume":"33","author":"Gounder","year":"2022","journal-title":"Ann Oncol"},{"key":"crv240003r28","doi-asserted-by":"publisher","first-page":"11523","DOI":"10.1200\/JCO.2022.40.16_suppl.11523","article-title":"Results of a phase I dose escalation and expansion study of tegavivint (BC2059), a first-in-class TBL-1 inhibitor for patients with progressive, unresectable desmoid tumor.","volume":"40","author":"Cranmer","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2820212\/jamaoncology_kasper_2024_rv_240003_1723659859.22848.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:27Z","timestamp":1723719747000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2820212"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2024.1805","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}